WHO issues rapid communication on key updates to the treatment of drug-resistant tuberculosis
First meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
South Africa prepares for future respiratory pathogen pandemics
Humanitarian pauses vital for critical polio vaccination campaign in the Gaza Strip
WHO offers new online course on building resilient health systems
WHO releases updated Target Product Profiles for tuberculosis diagnosis and detection of drug resistance
WHO Director-General declares mpox outbreak a public health emergency of international concern
Statement of the Thirty-ninth Meeting of the Polio IHR Emergency Committee
WHO invites mpox vaccine manufacturers to submit dossiers for emergency evaluation
Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg
